Neuroendocrine cancers
Researchers around the world are looking at improving the diagnosis and treatment of neuroendocrine cancer.
Go to Cancer Research UK's clinical trials database if you are looking for a trial for neuroendocrine cancer in the UK. You need to talk to your specialist if there are any trials that you think you might be able to take part in.
All cancer treatments must be fully researched before they can be used for everyone. This is so we can be sure that:
they work
they work better than the treatments already available
they are safe
To make sure the research is accurate, each trial has certain entry conditions for who can take part. These are different for each trial.
Hospitals do not take part in every clinical trial. Some trials are only done in a small number of hospitals, or in one area of the country. You may need to travel quite far if you take part in these trials.
Some of the trials on this page have now stopped recruiting people. It takes time before the results are available. This is because the trial team follow the patients for a period of time and collect and analyse the results. We have included this ongoing research to give examples of the type of research being carried out in neuroendocrine cancer.
Doctors are always looking for better ways to diagnose people with cancer.
Researchers are taking blood, urine and tissue samples from people with symptoms that could be due to cancers in the pancreas. This includes pancreatic neuroendocrine cancers. They are looking for certain . And they want to find out why some people are more likely to develop cancer than others.
Researchers want to improve treatment for people with neuroendocrine cancer.
Targeted drugs change the way that cells work. For example, they can block signals that tell cells to grow. Immunotherapies can boost the body’s own immune system to fight off or kill cancer cells.
There are different types of targeted cancer drugs and immunotherapies. Researchers are looking at different drugs for fast growing (high grade) neuroendocrine cancer. These include:
pembrolizumab
lenvatinib
Researchers are looking at these drugs with the chemotherapy drugs carboplatin and etoposide. Pembrolizumab and lenvatinib are already treatments for some other types of cancer. But not yet neuroendocrine cancer. And not with each other or with carboplatin and etoposide.
Read more about what high grade means
Researchers around the world are looking at other immunotherapy and targeted drugs. These are for high grade neuroendocrine cancers. Drugs include:
ipilimumab
nivolumab
atezolizumab
durvalumab
belzutifan
Go to the cancer drugs A to Z list
PRRT is a type of radioisotope therapy. These treatments use medicines to treat cancer. You have the radioactive substance as a drip into a vein.
Researchers are looking at:
how well PRRT helps people with ) that have spread to other parts of the body and who can't have surgery
how well PRRT helps people after surgery to remove cancer from the liver
giving a drug before PRRT to see if it makes it work better for some people with NETs that have spread
Doctors are looking at how the treatment and illness affect people with neuroendocrine cancer. These are called quality of life studies.
One study is looking at how a mobile application ( ) might help with recording symptoms and side effects of treatment. Researchers want to see if using this type of technology can improve quality of life for people with neuroendocrine cancer.
Find out about what researchers should tell you before you agree to take part in a trial
Last reviewed: 05 Mar 2025
Next review due: 05 Mar 2028
Clinical trials are medical research studies involving people. They help us to understand more about cancer and how we treat it.
There are many different types of neuroendocrine cancer. They are usually named after the part of the body where they develop.
Practical and emotional support is available to help you cope with neuroendocrine cancer.
Neuroendocrine cancers are also called neuroendocrine neoplasms (NENs). There are 2 key groups - neuroendocrine tumours (NETs) and neuroendocrine carcinomas (NECs).
Treatment depends on the type of neuroendocrine cancer you have, where it is, its size and whether it has spread (the stage).
A pathologist reports how abnormal the cancer cells look (differentiation) and how quickly they are growing (grading). Your stage is the size of the cancer and whether it has spread.

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.